PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 61919

The influence of azathioprine on the behaviour of blood platelets in vitro.

B Bogdanikowa·M Myśliwiec·M Bielawiec·B Kiersnowska-Rogowska
View original source ↗Export metadata ↓

Abstract

The influence of azathioprine on human platelets was studied in vitro. Azathioprine in a final concentration of 10(-4) M caused significant inhibition of spontaneous sedimentation and aggregation of platelets, but did not effect platelet adhesiveness or resistance to freezing and thawing. The influence of azathioprine is probably due to thioimidazole, this last being a potent stimulating agent of phosphodiesterase activity, involved in the metabolism of cyclic AMP to 5' AMP. These observations indicate that the widely used platelet function assays could be influenced by drugs. The current therapy should therefore be taken into account when the results of the tests are evaluated for clinical purposes.

Explore related subjects

AzathioprineBlood PlateletsCell MembraneHumansIn Vitro TechniquesPlatelet AdhesivenessPlatelet AggregationJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B Bogdanikowa, M Myśliwiec, M Bielawiec, B Kiersnowska-Rogowska. 1976. The influence of azathioprine on the behaviour of blood platelets in vitro.. https://pubmed.ncbi.nlm.nih.gov/61919/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1979

[Results of 200 renal transplantations (author's transl)].

Two hundred renal transplantations were performed on 187 patients between July, 1972 and June, 1978. On a follow-up of 6--78 months the survival rate after allogenic transplantation was 80% at one year and 64% at five years. Satisfactory renal function was present in 62% at one year and 31% at six years. Gastrointestinal complications were common and caused about 40% of all deaths. Severe infections were the second most common cause of death. Local complications required explantation in 4%, and caused death in 0.5% of cases. Change in the treatment regimen, using less massive immunosuppressive measures during acute rejection, lowered the death-rate without a higher loss of transplants. The death-rate was 16% at three months and 26% at one year in the first of the 200 transplantations, but 6% and 12%, respectively, in the last 50 consecutive transplantations. The survival rate of patients with transplants is thus comparable to that of patients receiving chronic haemodialysis.

Azathioprine↗